KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Idexx Laboratories (IDXX) Long-Term Debt Issuances (2016 - 2023)

Idexx Laboratories has reported Long-Term Debt Issuances over the past 14 years, most recently at $6.3 million for Q2 2023.

  • Quarterly results put Long-Term Debt Issuances at $6.3 million for Q2 2023, up 101.93% from a year ago — trailing twelve months through Jun 2023 was -$320.2 million (changed N/A YoY), and the annual figure for FY2025 was $250.0 million, changed.
  • Long-Term Debt Issuances for Q2 2023 was $6.3 million at Idexx Laboratories, up from -$559.5 million in the prior quarter.
  • Over the last five years, Long-Term Debt Issuances for IDXX hit a ceiling of $559.5 million in Q3 2022 and a floor of -$559.5 million in Q4 2022.
  • Median Long-Term Debt Issuances over the past 4 years was $100.0 million (2019), compared with a mean of $43.8 million.
  • Biggest five-year swings in Long-Term Debt Issuances: surged 140.4% in 2019 and later soared 101.93% in 2023.
  • Idexx Laboratories' Long-Term Debt Issuances stood at $100.0 million in 2019, then skyrocketed by 100.0% to $200.0 million in 2020, then crashed by 379.75% to -$559.5 million in 2022, then surged by 101.13% to $6.3 million in 2023.
  • The last three reported values for Long-Term Debt Issuances were $6.3 million (Q2 2023), -$559.5 million (Q4 2022), and $559.5 million (Q3 2022) per Business Quant data.